There is a possibility of further clarifications from Donald Trump regarding the pharma tariffs, and until then, the pharma sector is expected to remain under negative sentiment.
"he may come up with certain clarifications as well but as of now what we know is that the pharma sector is now pushed into a negative sentiment until and unless few more clarifications come up"
